CorMedix (CRMD) Accumulated Expenses (2010 - 2026)

CorMedix has reported Accumulated Expenses for 15 years, with the latest figure at $16.9 million in Q4 2025.

• Quarterly Accumulated Expenses rose 158.09% year-over-year to $16.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.9 million (up 158.09% YoY) and the FY2025 annual result came in at $16.9 million, up 158.09% from the prior year.
• Accumulated Expenses climbed to $16.9 million in Q4 2025 per CRMD's latest filing, from $806506.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $16.9 million in Q4 2025 and troughed at $806506.0 in Q3 2025.
• A 5-year average of $4.1 million and a median of $3.1 million in 2021 frame the typical range for Accumulated Expenses.
• The widest YoY moves for Accumulated Expenses: up 158.09% in 2025, down 83.16% in 2025.
• Over 5 years, Accumulated Expenses stood at $3.0 million in 2021, then surged by 31.84% to $4.0 million in 2022, then slumped by 31.59% to $2.7 million in 2023, then soared by 140.18% to $6.5 million in 2024, then soared by 158.09% to $16.9 million in 2025.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $16.9 million, $806506.0, and $3.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.